Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06747091 · ClinicalTrials.gov registry record · NA
ARIADNE Clinical Trial
A NA study of Persistent Atrial Fibrillation, sponsored by Stavros E Mountantonakis.
- Recruiting
- Registry status
- NA
- Development phase
- 60
- Enrollment target
- 3
- Study locations
NCT06747091: Recruiting NA study of Persistent Atrial Fibrillation, sponsored by Stavros E Mountantonakis.
NCT06747091 is a NA study of Persistent Atrial Fibrillation that is actively recruiting participants, run by Stavros E Mountantonakis. The registered enrollment target is 60 participants, below the 1,256-participant average among 15 other Persistent Atrial Fibrillation trials with a reported enrollment target (95% lower). The trial reports 3 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06747091, a NA study of Persistent Atrial Fibrillation, is actively recruiting participants, sponsored by Stavros E Mountantonakis.
- RECRUITING
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
- 3
- Study locations
Study Summary
A prospective multi-arm parallel group randomized clinical trial to compare the efficacy of three ablation strategies in patients with persistent atrial fibrillation using using a lattice-tip catheter that can switch between RFA and PFA energy. The incremental benefit of posterior wall isolation (PWI) and mitral isthmus ablation may contribute to greater freedom from atrial fibrillation at twelve months.
Primary Outcome
The primary effectiveness endpoint is freedom from documented recurrence of AF, atrial tachycardia (AT), or atrial flutter (AFL) lasting \>2 minutes based on electrocardiographic data through 12-month follow-up and excluding a 60-day blanking period.
Conditions Studied
Interventions
- PROCEDURE Catheter Ablation
Study Locations (3)
New York
- North Shore University Hospital - Manhasset
- Long Island Jewish Medical Center - New Hyde Park
- Kristie Coleman - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2025-03-18 |
| Est. Completion | 2027-03-01 |
| Phase | NA |
What NCT06747091 shows while recruiting
NCT06747091 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 1,256-participant average among 15 other Persistent Atrial Fibrillation trials with a reported enrollment target (95% lower).
The record links to 1 condition, with Persistent Atrial Fibrillation appearing as the primary indexed condition, and to 1 intervention - of which Catheter Ablation is the first listed.
NCT06747091 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT06747091 about?
NCT06747091 is a clinical study titled "ARIADNE Clinical Trial". A prospective multi-arm parallel group randomized clinical trial to compare the efficacy of three ablation strategies in patients with persistent atrial fibrillation using using a lattice-tip catheter that can switch between RFA and PFA energy. The incremental benefit of posterior wall isolation (PW...
What is the current status of trial NCT06747091?
This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2025-03-18. Estimated completion is 2027-03-01.
What conditions does trial NCT06747091 study?
This clinical trial studies the following conditions: Persistent Atrial Fibrillation.
What interventions are being tested in trial NCT06747091?
The interventions under investigation include: Catheter Ablation (PROCEDURE).
Who is sponsoring clinical trial NCT06747091?
This trial is sponsored by Stavros E Mountantonakis, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06747091 being conducted?
This trial has 3 study locations across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Persistent Atrial Fibrillation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06747091's enrollment target sits among peer trials
60 16th of 15 the lowest of 15 other Persistent Atrial Fibrillation trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Persistent Atrial Fibrillation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Endocardial Mapping With the CoreMap EP Mapping System
RECRUITING · NA
-
ULTRA-HFIB-Redo: Ultrasound-based Renal Sympathetic Denervation vs Control in Redo Ablation Patients
RECRUITING · NA
-
Medtronic Terminate AF Study
RECRUITING · NA
-
Repeat Ablation of Persistent Atrial Fibrillation, Including Mitral Isthmus Catheter Ablation, With the FARAPULSE Pulsed Field Ablation System
RECRUITING · NA
-
Pulsed Field Ablation (PFA) vs Anti-Arrhythmic Drug (AAD) Therapy as a First Line Treatment for Persistent Atrial Fibrillation
ACTIVE NOT RECRUITING · NA
-
AtriCure CryoICE Lesions for Persistent and Long-standing Persistent Atrial Fibrillation Treatment
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI